Hyperoxaluria-induced oxidative stress and antioxidants for renal protection
- PMID: 16292585
- DOI: 10.1007/s00240-005-0492-4
Hyperoxaluria-induced oxidative stress and antioxidants for renal protection
Abstract
Renal cellular exposure to oxalate (Ox) and/or CaOx crystals leads to the production of reactive oxygen species (ROS), development of oxidative stress followed by injury and inflammation. Renal injury and inflammation appear to play a significant role in stone formation. ROS are produced from many sources and involve a variety of signaling pathways. Tissue culture and animal model studies show that treatments with anti-oxidants and free radical scavengers reduce Ox/CaOx crystal induced injuries. In addition, CaOx crystal deposition in kidneys is significantly reduced by treatments with antioxidants and free radical scavengers, indicating their efficacy. These results point towards a great potential for the therapeutic application of antioxidants and free radical scavengers to reduce stone recurrence particularly after shock wave lithotripsy, which is itself known to generate ROS and cause renal damage.
Similar articles
-
Opportunities for future therapeutic interventions for hyperoxaluria: targeting oxidative stress.Expert Opin Ther Targets. 2019 May;23(5):379-391. doi: 10.1080/14728222.2019.1599359. Epub 2019 Apr 1. Expert Opin Ther Targets. 2019. PMID: 30905219 Review.
-
Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.BJU Int. 2005 Jul;96(1):117-26. doi: 10.1111/j.1464-410X.2005.05579.x. BJU Int. 2005. PMID: 15963133
-
Inhibition of AT1R/IP3/IP3R-mediated Ca2+ release protects against calcium oxalate crystals-induced renal oxidative stress.Chem Biol Interact. 2023 Sep 1;382:110636. doi: 10.1016/j.cbi.2023.110636. Epub 2023 Jul 15. Chem Biol Interact. 2023. PMID: 37454925
-
Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress.Oxid Med Cell Longev. 2018 Apr 24;2018:1271864. doi: 10.1155/2018/1271864. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29849862 Free PMC article.
-
Hyperoxaluria: a gut-kidney axis?Kidney Int. 2011 Dec;80(11):1146-58. doi: 10.1038/ki.2011.287. Epub 2011 Aug 24. Kidney Int. 2011. PMID: 21866092 Review.
Cited by
-
Porous Se@SiO2 nanocomposites play a potential inhibition role in hyperoxaluria associated kidney stone by exerting antioxidant effects.Transl Androl Urol. 2024 Apr 30;13(4):526-536. doi: 10.21037/tau-23-511. Epub 2024 Apr 18. Transl Androl Urol. 2024. PMID: 38721282 Free PMC article.
-
Efficacy of an Oral Solution Containing Five Herbal Extracts in the Treatment of Urolithiasis: A Randomized, Single-blind, Placebo-controlled Clinical Trial.J Res Pharm Pract. 2024 Apr 30;12(3):96-103. doi: 10.4103/jrpp.jrpp_11_24. eCollection 2023 Jul-Sep. J Res Pharm Pract. 2024. PMID: 38716323 Free PMC article.
-
Antiurolithiasis activities of Zea mays extract and its mechanism as antiurolithiasis remedy.Am J Clin Exp Urol. 2023 Oct 15;11(5):443-451. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 37941649 Free PMC article.
-
Hydroxycitric acid prevents hyperoxaluric-induced nephrolithiasis and oxidative stress via activation of the Nrf2/Keap1 signaling pathway.Cell Cycle. 2023 Sep;22(17):1884-1899. doi: 10.1080/15384101.2023.2247251. Epub 2023 Aug 17. Cell Cycle. 2023. PMID: 37592762
-
Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence.Asian J Urol. 2023 Jul;10(3):246-257. doi: 10.1016/j.ajur.2023.01.008. Epub 2023 Apr 13. Asian J Urol. 2023. PMID: 37538166 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical